Susceptibility of the anaerobic gram-negative non-sporulating rod, Bilophila wadsworthia to beta-lactams, beta-lactamase inhibitors, meropenem, metronidazole, clindamycin and quinolones

Zentralbl Bakteriol. 1998 May;287(4):421-5. doi: 10.1016/s0934-8840(98)80179-5.

Abstract

The susceptibility of eighty-seven strain of Bilophila wadsworthia to five beta-lactams, two beta-lactamase inhibitors, meropenem, metronidazole, clindamycin and two quinolones was determined. Tests were performed by the modified reference agar dilution technique using triphenyltetrazolium chloride for endpoint reading. The test strains showed a reduced susceptibility to the beta-lactams, penicillin G (MIC90 4 micrograms/ml), ampicillin (MIC90 32 micrograms/ml), piperacillin (MIC90 64 micrograms/ml), cephalothin (MIC90 2 micrograms/ml and cefotaxim (MIC90 4 micrograms/ml). The activity of ampicillin was increased by addition of the beta-lactamase inhibitor, sulbactam (MIC90 2 micrograms/ml), as was the activity of piperacillin by the addition of tazobactam (MIC90 4 micrograms/ml) 90.8% of the strains were found to produce beta-lactamase by the nitrocefin tube method. All strains were shown to be highly susceptible to meropenem, metronidazole and clindamycin (MICs < or = 1 microgram/ml). Sparfloxacin (MIC90 1 microgram/ml) and ciprofloxacin (MIC90 0.5 microgram/ml) were found to be active against most of the strains tested.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Clindamycin / pharmacology*
  • Gram-Negative Anaerobic Straight, Curved, and Helical Rods / drug effects*
  • Meropenem
  • Metronidazole / pharmacology*
  • Microbial Sensitivity Tests
  • Quinolones / pharmacology*
  • Thienamycins / pharmacology*
  • beta-Lactamase Inhibitors*
  • beta-Lactams / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Quinolones
  • Thienamycins
  • beta-Lactamase Inhibitors
  • beta-Lactams
  • Metronidazole
  • Clindamycin
  • Meropenem